$242 Million is the total value of SILVERARC CAPITAL MANAGEMENT, LLC's 69 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 45.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | Buy | SPDR SER TRcall | $26,964,000 | +20.4% | 300,000 | +50.0% | 11.16% | +23.0% |
| ATHA | New | ATHIRA PHARMA INC | $26,964,000 | – | 10,000 | +100.0% | 11.16% | – |
| ITCI | Buy | INTRA-CELLULAR THERAPIES INC | $18,897,000 | +85.2% | 308,819 | +58.4% | 7.82% | +89.1% |
| SRRA | Buy | SIERRA ONCOLOGY INC | $14,210,000 | +240.4% | 443,381 | +130.9% | 5.88% | +247.5% |
| VCYT | Buy | VERACYTE INC | $11,733,000 | +28.7% | 425,554 | +92.2% | 4.86% | +31.4% |
| CTIC | Buy | CTI BIOPHARMA CORP | $10,508,000 | +185.5% | 2,250,000 | +51.6% | 4.35% | +191.6% |
| MRUS | Buy | MERUS N V | $8,586,000 | -15.7% | 324,719 | +1.4% | 3.55% | -13.9% |
| CERS | Buy | CERUS CORP | $7,677,000 | +8.1% | 1,398,400 | +34.1% | 3.18% | +10.4% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $7,096,000 | +6.7% | 67,442 | +9.3% | 2.94% | +9.0% |
| APEN | Buy | APOLLO ENDOSURGERY INC | $6,077,000 | -2.5% | 1,004,399 | +35.8% | 2.52% | -0.5% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $5,354,000 | – | 105,368 | +100.0% | 2.22% | – |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $4,747,000 | +14.1% | 275,333 | -3.8% | 1.96% | +16.4% |
| ITOS | Buy | ITEOS THERAPEUTICS INC | $4,468,000 | -30.5% | 138,843 | +0.6% | 1.85% | -29.0% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $4,359,000 | -60.6% | 102,497 | +27.6% | 1.80% | -59.8% |
| COGT | Sell | COGENT BIOSCIENCES INC | $4,297,000 | -41.1% | 573,699 | -32.6% | 1.78% | -39.9% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $3,792,000 | -57.5% | 46,122 | -24.1% | 1.57% | -56.6% |
| IMTX | Buy | IMMATICS N.V | $3,558,000 | -32.3% | 445,334 | +13.9% | 1.47% | -30.9% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $3,093,000 | -5.3% | 46,489 | -0.4% | 1.28% | -3.3% |
| IMGN | Sell | IMMUNOGEN INC | $3,070,000 | -72.7% | 645,000 | -57.4% | 1.27% | -72.1% |
| NGM | New | NGM BIOPHARMACEUTICALS INC | $3,058,000 | – | 200,494 | +100.0% | 1.26% | – |
| OTIC | Buy | OTONOMY INC | $2,898,000 | +16.1% | 1,207,385 | +0.6% | 1.20% | +18.5% |
| MORF | Buy | MORPHIC HLDG INC | $2,759,000 | -13.6% | 68,709 | +1.9% | 1.14% | -11.8% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $2,662,000 | -15.3% | 14,836 | +2.0% | 1.10% | -13.5% |
| GLPG | Sell | GALAPAGOS NVspon adr | $2,543,000 | -64.2% | 41,002 | -68.2% | 1.05% | -63.5% |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $2,502,000 | -21.3% | 114,004 | +1.9% | 1.04% | -19.6% |
| INSM | Buy | INSMED INC | $2,399,000 | -12.5% | 102,067 | +1.4% | 0.99% | -10.6% |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $2,332,000 | -4.7% | 126,136 | +1.9% | 0.96% | -2.7% |
| MCRB | Buy | SERES THERAPEUTICS INC | $2,327,000 | -12.9% | 326,872 | +2.0% | 0.96% | -11.0% |
| EYPT | Buy | EYEPOINT PHARMACEUTICALS INC | $2,256,000 | +1.3% | 185,666 | +2.1% | 0.93% | +3.5% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $1,993,000 | +81.5% | 7,638 | +52.8% | 0.82% | +85.4% |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $1,920,000 | – | 20,482 | +100.0% | 0.80% | – |
| LPTX | Buy | LEAP THERAPEUTICS INC | $1,806,000 | -45.0% | 1,032,163 | +1.8% | 0.75% | -43.9% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $1,763,000 | -19.5% | 101,447 | +1.4% | 0.73% | -17.7% |
| VRAY | Buy | VIEWRAY INC | $1,709,000 | -27.5% | 436,096 | +1.9% | 0.71% | -26.0% |
| JNCE | Buy | JOUNCE THERAPEUTICS INC | $1,686,000 | -17.9% | 248,347 | +1.0% | 0.70% | -16.1% |
| CDXS | New | CODEXIS INC | $1,670,000 | – | 81,000 | +100.0% | 0.69% | – |
| PNT | Buy | POINT BIOPHARMA GLOBAL INC | $1,631,000 | +42.4% | 204,679 | +0.1% | 0.68% | +45.5% |
| FMTX | New | FORMA THERAPEUTICS HLDGS INC | $1,625,000 | – | 174,768 | +100.0% | 0.67% | – |
| ISEE | New | IVERIC BIO INCput | $1,592,000 | – | 94,600 | +100.0% | 0.66% | – |
| ASLN | Sell | ASLAN PHARMACEUTICALS LTDads | $1,592,000 | -5.1% | 500,000 | -66.6% | 0.66% | -3.1% |
| SGEN | Buy | SEAGEN INC | $1,578,000 | -5.9% | 10,956 | +1.0% | 0.65% | -4.0% |
| IMGN | New | IMMUNOGEN INCcall | $1,428,000 | – | 300,000 | +100.0% | 0.59% | – |
| XENE | Buy | XENON PHARMACEUTICALS INC | $1,428,000 | -54.3% | 101,081 | +1.1% | 0.59% | -53.3% |
| ASND | New | ASCENDIS PHARMA A/Ssponsored adr | $1,428,000 | – | 25,000 | +100.0% | 0.59% | – |
| CYCC | Buy | CYCLACEL PHARMACEUTICALS INC | $1,411,000 | -20.9% | 462,659 | +0.9% | 0.58% | -19.2% |
| STXS | Buy | STEREOTAXIS INC | $1,292,000 | -39.5% | 346,405 | +0.6% | 0.54% | -38.2% |
| MSAC | Buy | MEDICUS SCIENCES ACQUISITION | $1,283,000 | +3.0% | 131,151 | +2.0% | 0.53% | +5.1% |
| AMYT | Sell | AMRYT PHARMA PLCsponsored ads | $1,268,000 | -66.5% | 153,267 | -56.2% | 0.52% | -65.8% |
| PYPD | Buy | POLYPID LTD | $1,191,000 | -3.8% | 218,175 | +1.2% | 0.49% | -1.8% |
| LHDX | Sell | LUCIRA HEALTH INC | $1,109,000 | -75.0% | 310,734 | -39.7% | 0.46% | -74.5% |
| ELOX | Buy | ELOXX PHARMACEUTICALS INC | $1,092,000 | -19.9% | 1,950,949 | +1.1% | 0.45% | -18.1% |
| PSTX | Buy | POSEIDA THERAPEUTICS INC | $1,074,000 | -32.9% | 239,696 | +2.0% | 0.44% | -31.5% |
| NXTC | Buy | NEXTCURE INC | $953,000 | -17.7% | 196,187 | +1.6% | 0.39% | -16.0% |
| CGEN | Buy | COMPUGEN LTDord | $865,000 | +23.7% | 268,596 | +65.2% | 0.36% | +26.5% |
| IMUX | New | IMMUNIC INC | $774,000 | – | 68,475 | +100.0% | 0.32% | – |
| New | ELIEM THERAPEUTICS INC | $741,000 | – | 88,279 | +100.0% | 0.31% | – | |
| APTX | New | APTINYX INCput | $458,000 | – | 201,600 | +100.0% | 0.19% | – |
| New | AMYLYX PHARMACEUTICALS INC | $386,000 | – | 30,000 | +100.0% | 0.16% | – | |
| EVGN | Buy | EVOGENE LTD | $384,000 | -20.2% | 295,746 | +0.9% | 0.16% | -18.5% |
| MREO | Buy | MEREO BIOPHARMA GROUP PLCads | $264,000 | -29.2% | 235,515 | +1.0% | 0.11% | -27.8% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $256,000 | -85.3% | 45,538 | +0.9% | 0.11% | -85.0% |
| BIIB | Buy | BIOGEN INC | $230,000 | -83.3% | 10,248 | +78.4% | 0.10% | -83.0% |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $197,000 | – | 102,425 | +100.0% | 0.08% | – |
| BLU | Buy | BELLUS HEALTH INC NEW | $177,000 | -98.0% | 1,235,784 | +12.3% | 0.07% | -98.0% |
| CALA | Buy | CALITHERA BIOSCIENCES INC | $74,000 | -49.3% | 221,809 | +0.9% | 0.03% | -47.5% |
| BNTC | Sell | BENITEC BIOPHARMA INC | $57,000 | -96.3% | 492,880 | -16.1% | 0.02% | -96.2% |
| RENOVACOR INC*w exp 99/99/999 | $33,000 | -45.0% | 104,828 | 0.0% | 0.01% | -41.7% | ||
| ALGS | New | ALIGOS THERAPEUTICS INC | $23,000 | – | 10,659 | +100.0% | 0.01% | – |
| MSACW | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $21,000 | -41.7% | 49,990 | 0.0% | 0.01% | -40.0% | |
| CGEN | Exit | COMPUGEN LTDcall | $0 | – | -57,000 | -100.0% | -0.10% | – |
| VTGN | Exit | VISTAGEN THERAPEUTICS INC | $0 | – | -424,181 | -100.0% | -0.34% | – |
| IPHA | Exit | INNATE PHARMA S Asponsored ads | $0 | – | -184,046 | -100.0% | -0.34% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -66,812 | -100.0% | -0.38% | – |
| CRIS | Exit | CURIS INCcall | $0 | – | -200,000 | -100.0% | -0.39% | – |
| INBX | Exit | INHIBRX INC | $0 | – | -24,666 | -100.0% | -0.44% | – |
| DNAD | Exit | SOCIAL CAP SUVRETTA HLDS CP | $0 | – | -123,862 | -100.0% | -0.49% | – |
| DNAB | Exit | SOCIAL CAP SUVRETTA HLDS CRP | $0 | – | -123,862 | -100.0% | -0.50% | – |
| DNAC | Exit | SOCIAL CAP SUVRETTA HLD CRPI | $0 | – | -123,862 | -100.0% | -0.50% | – |
| DNAA | Exit | SOCIAL CAP SUVRETTA HLDS CRP | $0 | – | -123,862 | -100.0% | -0.50% | – |
| HLXA | Exit | HELIX ACQUISITION CORP | $0 | – | -131,823 | -100.0% | -0.53% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -160,526 | -100.0% | -0.64% | – |
| BBIO | Exit | BRIDGEBIO PHARMA INC | $0 | – | -100,000 | -100.0% | -0.68% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.93% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -58,190 | -100.0% | -1.08% | – |
| HALO | Exit | HALOZYME THERAPEUTICS INC | $0 | – | -71,009 | -100.0% | -1.16% | – |
| RACB | Exit | RESEARCH ALLIANCE CORP II | $0 | – | -556,890 | -100.0% | -2.20% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTRA-CELLULAR THERAPIES INC | 12 | Q3 2023 | 7.8% |
| IMMUNOGEN INC | 12 | Q3 2023 | 8.3% |
| Morphic Holding Inc | 12 | Q3 2023 | 4.5% |
| UNUM THERAPEUTICS INC | 12 | Q3 2023 | 3.2% |
| INSMED INC | 12 | Q3 2023 | 3.5% |
| UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 2.2% |
| MERUS N V | 11 | Q3 2023 | 5.1% |
| VERACYTE INC | 11 | Q3 2023 | 4.9% |
| EVOGENE LTD | 11 | Q3 2023 | 1.6% |
| COMPUGEN LTD | 11 | Q3 2023 | 1.1% |
View SILVERARC CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Benitec Biopharma Inc.Sold out | February 08, 2023 | 0 | 0.0% |
| DELCATH SYSTEMS, INC.Sold out | February 08, 2022 | 0 | 0.0% |
View SILVERARC CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G/A | 2023-02-08 |
| 13F-HR | 2022-10-28 |
View SILVERARC CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.